These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


125 related items for PubMed ID: 23802568

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of oral administration of diphenhydramine on pupil diameter, intraocular pressure, tear production, tear film quality, conjunctival goblet cell density, and corneal sensitivity of clinically normal adult dogs.
    Evans PM, Lynch GL, Labelle P.
    Am J Vet Res; 2012 Dec; 73(12):1983-6. PubMed ID: 23176427
    [Abstract] [Full Text] [Related]

  • 4. Ocular surface abnormalities related to type 2 diabetes are reversed by the opioid antagonist naltrexone.
    Zagon IS, Sassani JW, Immonen JA, McLaughlin PJ.
    Clin Exp Ophthalmol; 2014 Mar; 42(2):159-68. PubMed ID: 23777539
    [Abstract] [Full Text] [Related]

  • 5. Dry eye reversal and corneal sensation restoration with topical naltrexone in diabetes mellitus.
    Zagon IS, Klocek MS, Sassani JW, McLaughlin PJ.
    Arch Ophthalmol; 2009 Nov; 127(11):1468-73. PubMed ID: 19901212
    [Abstract] [Full Text] [Related]

  • 6. Development of tear production and intraocular pressure in healthy canine neonates.
    Verboven CA, Djajadiningrat-Laanen SC, Teske E, Boevé MH.
    Vet Ophthalmol; 2014 Nov; 17(6):426-31. PubMed ID: 25041368
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Naltrexone and insulin are independently effective but not additive in accelerating corneal epithelial healing in type I diabetic rats.
    Klocek MS, Sassani JW, McLaughlin PJ, Zagon IS.
    Exp Eye Res; 2009 Nov; 89(5):686-92. PubMed ID: 19576213
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Topically applied naltrexone restores corneal reepithelialization in diabetic rats.
    Klocek MS, Sassani JW, McLaughlin PJ, Zagon IS.
    J Ocul Pharmacol Ther; 2007 Apr; 23(2):89-102. PubMed ID: 17444796
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Topical Application of Naltrexone to the Ocular Surface of Healthy Volunteers: A Tolerability Study.
    Liang D, Sassani JW, McLaughlin PJ, Zagon IS.
    J Ocul Pharmacol Ther; 2016 Mar; 32(2):127-32. PubMed ID: 26741052
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.